DFM Platform
DFM Funding Monitor

Revolutionary high-resolution human 3D brain organoid platform integrating AI-based analyticsbroad

3D-BrAIn · Horizon Europe grant · 2023-04-01–2028-03-31

EC contribution

€1,998,347

Total cost

€2,003,348

Beneficiaries

4
About the data

Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2022-PATHFINDEROPEN-01 · scheme HORIZON-EIC · topic HORIZON-EIC-2022-PATHFINDEROPEN-01-01. CORDIS record →

Objective

The long-term vision of the 3D-BrAIn consortium is to revolutionize personalized precision medicine for central nervous system (CNS)disorders, by developing an innovative bio-digital twin model of the human brain that is personalized, precise, and predictive.In this pathfinder project we bring together three breakthrough technologies: 1) a novel, highly reproducible human brain modellingtechnology using robust adherent iPSC-derived 3D cortical organoid cultures, 2) a unique, state-of-the-art 3D multi-electrode array(MEA) technology for non-invasive high-resolution electrophysiological recordings and 3) a novel approach to analyse and interpretthe large quantities of functional data using tailored automated machine learning (ML)-based algorithms.With this breakthrough approach we overcome significant hurdles that made it thus far impossible to create a truly representativeand functional model of the CNS for personalized medicine, drug screening and neurotoxicity testing. The revolutionary 3D-BrAInhigh-precision CNS platform will allow robust and accurate modelling of the CNS for a broad range of neuropsychiatric diseases.Ultimately, the 3D-BrAIn technology will be translatable to multiple other organ systems (cardiomyocytes, pancreatic islets, retina), tonon-invasively obtain longitudinal 3D high-resolution electrophysiological recordings and effectively interpret them.In this project a prototype of the 3D-BrAIn platform will be developed by growing functional 3D organoids that faithfully resemblethe human cortex on 3D MEA micropillar electrodes, enabling continuous functional monitoring and by developing ML-basedalgorithms that can process and interpret the large spatiotemporal data sets. Once all individual components are optimized andintegrated, proof-of-concept will be obtained by validating the platform for two of the envisaged applications: CNS drugdevelopment and neurotoxicity screening.

Beneficiaries (4)

OrganisationCountryRoleEC contributionSME
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM NL coordinator €1,133,750
UNIVERSITA DEGLI STUDI DI GENOVA IT participant €467,097
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE participant €397,500
3BRAIN AG CH associatedPartner Yes

Get the EU Defence Funding Calendar — free

The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.

We store your email to send the calendar and the weekly DFM Analysis briefing. Nothing else. Unsubscribe anytime.

Or browse all open defence & dual-use calls on the funding calendar →

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.

DFM Analysis, our free weekly newsletter, tracks the EU defence-funding programmes, calls and decisions behind this page. Subscribe free →